Surgery, chemotherapy, radiotherapy, and hormone therapy are the main common anti-
tumor therapeutic approaches. However, the non-specific targeting of cancer cells has made …

Myocardial infarction (MI) is a cardiovascular emergency and the leading cause of death
worldwide. Inflammatory and immune responses are initiated immediately after MI, leading …

Objectives Retrospective studies in patients with primary brain tumors or other central
nervous system pathologies as well as postmortem studies have suggested that gadolinium …

Recently, a great interest has been paid to the development of hybrid protein-inorganic
nanoparticles (NPs) for drug delivery and cancer diagnostics in order to combine the merits …

Myocardial infarction (MI) is the leading cause of morbidity and mortality worldwide. Despite
extensive efforts to provide early diagnosis and adequate treatment regimens, detection of …

Successful therapy and diagnosis of glioma is one of the biggest challenges in the
biomedical fields. The incidence is growing gradually around the world. Annually, there are …

Highly aggressive cancer types such as pancreatic cancer possess a mortality rate of up to
80% within the first 6 months after diagnosis. To reduce this high mortality rate, more …

Engineered proteins provide an interesting template for designing fluorine-19 (19F)
magnetic resonance imaging (MRI) contrast agents, yet progress has been hindered by the …

Molecular imaging agents enable the visualization of phenomena with cellular and
subcellular level resolutions and therefore have enormous potential in improving disease …

CEND-1 (iRGD) is a bifunctional cyclic peptide that can modulate the solid tumour
microenvironment, enhancing the delivery and therapeutic index of co-administered anti …